Search results
- 1.0560439 - FGÚ 2023 RIV CH eng J - Journal Article
Malínská, H. - Hüttl, M. - Marková, I. - Miklánková, D. - Hojná, Silvie - Papoušek, František - Šilhavý, Jan - Mlejnek, Petr - Zicha, Josef - Hrdlička, Jaroslav - Pravenec, Michal - Vaněčková, Ivana
Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein.
Biomedicines. Roč. 10, č. 9 (2022), č. článku 2066. E-ISSN 2227-9059
R&D Projects: GA ČR(CZ) GA19-06199S; GA MŠMT(CZ) LX22NPO5104
Institutional support: RVO:67985823
Keywords : SHR-CRP * SGLT-2 inhibitor * gene expression * age * lipid metabolism
OECD category: Physiology (including cytology)
Impact factor: 4.7, year: 2022
Method of publishing: Open access
https://www.mdpi.com/2227-9059/10/9/2066
Permanent Link: https://hdl.handle.net/11104/0333368File Download Size Commentary Version Access 22_0073_0560439.pdf 0 1.9 MB Publisher’s postprint open-access - 2.0547427 - FGÚ 2022 RIV FR eng J - Journal Article
Hojná, Silvie - Rauchová, Hana - Malínská, H. - Marková, I. - Hüttl, M. - Papoušek, František - Behuliak, Michal - Miklánková, D. - Vaňourková, Z. - Neckář, Jan - Kadlecová, Michaela - Kujal, P. - Zicha, Josef - Vaněčková, Ivana
Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension.
Biomedicine & Pharmacotherapy. Roč. 144, Dec (2021), č. článku 112246. ISSN 0753-3322. E-ISSN 1950-6007
R&D Projects: GA ČR(CZ) GA19-06199S
Institutional support: RVO:67985823
Keywords : SGLT-2 inhibitor * cardiac * renal and metabolic parameters
OECD category: Physiology (including cytology)
Impact factor: 7.419, year: 2021
Method of publishing: Open access
https://doi.org/10.1016/j.biopha.2021.112246
Permanent Link: http://hdl.handle.net/11104/0323665